NCT02170558

Brief Summary

To determine if the subject metal reduction software helps to better visualize bone interphase and fusion reliability. Assess whether the appropriate procedural modification facilitates clearer images when implanted with a trabecular metal spinal implant

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2014

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

June 18, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 23, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

January 24, 2019

Status Verified

January 1, 2019

Enrollment Period

1.5 years

First QC Date

June 18, 2014

Last Update Submit

January 22, 2019

Conditions

Keywords

Trabecular MetalMetal reduction CTTM- Ardis

Outcome Measures

Primary Outcomes (1)

  • CT scan to determine if the study software can reduce metal scatter on the scan.

    Each CT scan will be evaluated to asses if you can visualize fusion, bone interface, and/or device migration with an experimental metal reduction software for CT scan

    6 month post operative

Study Arms (1)

Patients implanted w/TM-Ardis

Patients who are receiving a TM-Ardis implant for degenerative disc disease will have a CT scan immediate post op (2 weeks) and again at 6 months to determine if fusion can be assessed with the study metal reduction software. Will utilize TM- Ardis implant and Metal Reduction CT software

Device: TM- Ardis implant and Metal Reduction CT software

Interventions

TM- Ardis implant and Metal Reduction CT software

Patients implanted w/TM-Ardis

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients who are having a spinal fusion procedure with TM-Ardis and meet the requirements below are eligible for this study.

You may qualify if:

  • A signed informed consent.
  • Male or non-pregnant female scheduled for Trabecular Metal (TM - Ardis) implant, single level lumbar.
  • Participant must be at least 18 years of age.

You may not qualify if:

  • Patient is pregnant Patient is unable to comprehend the requirements of the study.
  • Patient is unable to undergo scanning (due to body habitus, inability to comply with positioning requirements, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St Alphonsus Regional Medical Center

Boise, Idaho, 83706, United States

Location

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Study Officials

  • Joel Batts

    Zimmer Biomet Spine

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 18, 2014

First Posted

June 23, 2014

Study Start

June 1, 2014

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

January 24, 2019

Record last verified: 2019-01

Locations